Human Milk Analyzers Market Size, Share, and Growth Forecast, 2026 - 2033

Human Milk Analyzers Market by Analyzer Type (Portable Human Milk Analyzers, Laboratory/Benchtop Human Milk Analyzers, Others), Technology (Near-Infrared (NIR) Analyzers, Mid-Infrared (MIR/FT-IR) Analyzers, Others), Application, End-user, and Regional Analysis for 2026 - 2033

ID: PMRREP27511
Calendar

October 2026

190 Pages

Author : Abhijeet Surwase

Human Milk Analyzers Market Size and Trends Analysis

The global human milk analyzers market size is likely to be valued at US$342.7 million in 2026 and is expected to reach US$522.1 million by 2033, growing at a CAGR of 6.2% between 2026 and 2033, driven by increasing use of individualized nutrition strategies for premature and low-birth-weight infants, where human milk composition can vary considerably.

Growing human milk banking activity and the clinical use of rapid macronutrient analysis are creating additional demand. Regulatory attention to donor-milk safety, traceability, quality assurance, and neonatal nutrition is further strengthening adoption.

Key Industry Highlights:

  • Leading Region: North America is projected to account for 34.8% of the market share, supported by advanced NICU infrastructure, established human milk banks, regulatory clarity, and strong clinical research activity.
  • Fastest-growing Region: Asia Pacific, driven by expanding neonatal-care infrastructure, donor human milk programs, and rising adoption of structured nutritional management across China, India, Japan, and Southeast Asia.
  • Dominant Analyzer Type: Portable human milk analyzers, anticipated to account for 63.5% of the market share, supported by their compact design and suitability for rapid analysis within NICUs, milk banks, and neonatal clinics.
  • Leading Technology: Near-infrared (NIR) analyzers, anticipated to hold 57.6% share, supported by rapid measurement, established spectroscopy methods, and suitability for routine macronutrient analysis.

human-milk-analyzers-market-2026-2033

See exactly what you're buying — Before you spend a dollar.

Get a free sample copy of our market report: data, tables, charts, research depth, analyst insights, and relevance of our research - all in hand before you commit.

DRO Analysis

Drivers - Rising Clinical Focus on Individualized Nutrition for Premature Infants

Preterm and very-low-birth-weight infants have high and changing nutritional requirements, while the composition of human milk varies according to factors including lactation stage, maternal characteristics, and collection timing. The World Health Organization estimates that 13.4 million preterm births occurred globally in 2020 and recommends mother’s own milk for preterm and low-birth-weight infants, with donor human milk considered when mother’s milk is unavailable.

Clinical research has also demonstrated the feasibility of rapid infrared analysis of human milk macronutrients. One validation study reported correlation coefficients of approximately 0.95 for both fat and protein using near-infrared analysis.

The commercial implication is that human milk analyzers can become part of routine neonatal nutrition workflows rather than remaining limited to research laboratories. Hospitals seeking to implement individualized fortification require timely information on milk composition to determine nutritional supplementation requirements. This creates demand not only for analyzers but also for calibration, maintenance, software, training, and related analytical services. As neonatal units increasingly focus on achieving appropriate nutrient intake and growth outcomes, the value proposition of rapid milk analysis becomes stronger.

Restraint - High Acquisition Costs and Demanding Validation Requirements

The principal restraint is the cost and complexity associated with deploying specialized analytical systems in hospitals and milk banks. Neonatal facilities already allocate significant capital to incubators, ventilators, monitoring equipment, laboratory systems, staffing, and other critical infrastructure. A human milk analyzer therefore needs to demonstrate sufficient clinical and operational value to justify additional capital expenditure.

Technical validation also remains important. Infrared measurements can be affected by sample homogenization, milk matrix characteristics, calibration models, instrument configuration, and handling conditions. Multicenter research involving 13 centers and 15 devices identified differences between systems that required device-specific correction procedures. Regulatory requirements can further increase development time and commercialization costs. The classification of dedicated systems as medical devices means manufacturers must establish analytical performance and intended-use claims before entering regulated markets. These factors can lengthen purchasing cycles and concentrate adoption in larger hospitals, academic medical centers, and established milk banks.

Opportunities - Integration of Analyzers with Digital Neonatal Nutrition Platforms

The market is increasingly moving toward integration between measurement hardware and digital clinical decision-support systems. Software platforms can combine measured milk composition with infant nutritional requirements to calculate fortification requirements, track nutritional intake, and support growth monitoring. This creates an opportunity to transform the analyzer from a standalone laboratory instrument into a broader neonatal nutrition-management solution.

Cloud-connected platforms can support centralized monitoring across hospital networks, milk banks, and neonatal units while improving access to historical analytical data. Integration with hospital information systems can further reduce manual data entry and allow milk-composition measurements to become part of a patient's broader nutritional record. Vendors that combine analytical hardware with software, calibration management, training, service contracts, and data connectivity can potentially increase recurring revenue while strengthening customer retention. The opportunity is particularly relevant for large healthcare networks seeking standardized neonatal nutrition protocols across multiple facilities.

Category-wise Analysis

Analyzer Type Insights

Portable human milk analyzers are anticipated to lead the market with a 63.5% share in 2026. Their position reflects the need for rapid milk-composition analysis within neonatal workflows, where results can support feeding and fortification decisions. Portable systems can be deployed directly in NICUs, milk banks, neonatal clinics, and research settings without relying on centralized laboratories. For example, the miris human milk analyzer measures fat, protein, and carbohydrate and provides additional nutritional parameters such as total solids and energy. Its compact design illustrates the growing preference for dedicated analysis close to milk-preparation and clinical-care areas.

Laboratory and benchtop human milk analyzers are anticipated to be the fastest-growing segment. Demand is supported by expanding milk banks, academic medical centers, and research programs requiring repeated analysis of larger sample volumes. Benchtop systems provide controlled operating conditions and standardized workflows, which are particularly useful for quality assurance and research. NIR-based laboratory analyzers and broader spectroscopy platforms are increasingly evaluated for human milk macronutrient analysis.

Handheld and point-of-care systems remain emerging categories, while consumer-oriented analyzers face greater challenges around validation, interpretation, and clinical utility.

Technology Insights

Near-infrared (NIR) analyzers are anticipated to account for 57.6% market share in 2026. NIR offers rapid measurement, established spectroscopy methods, and applications across milk and food analysis. Studies of human milk have demonstrated strong correlations between NIR measurements and reference methods for key macronutrients, supporting its use for rapid nutritional assessment. For example, dedicated NIR-based systems such as the Miris HMA demonstrate how spectroscopy can be incorporated into routine hospital and milk-bank workflows for measuring major milk components.

Mid-infrared (MIR) and FT-IR analyzers are anticipated to be the fastest-growing technology segment. These technologies provide detailed spectral information and can deliver high analytical accuracy when supported by appropriate calibration and sample preparation.

Research using FT-mid-infrared spectroscopy has reported strong performance for measuring protein and fat, including intra-assay coefficients of variation below 3% in selected studies. Their growing appeal reflects demand for greater analytical precision and broader milk characterization. Ultrasonic methods remain relevant for complementary analysis, while automated nutrient profiling and hybrid spectroscopy platforms create opportunities for digital, cloud-connected clinical systems.

human-milk-analyzers-market-outlook-by-analyzer-type-2026-2033

Not every business fits the same mold. Your research shouldn't either.

Connect with the team for a customization and get a one-of-a-kind report scoped to your niche — The insights your competitors won't have access to.

Regional Insights

North America Human Milk Analyzers Market Trends

North America is expected to lead the human milk analyzers market with an estimated 34.8% market share in 2026. The U.S. dominates owing to its advanced NICU network, academic medical centers, organized milk banks, and clinical research. The U.S. preterm birth rate was 10.4% in 2024, representing nearly 380,000 births. FDA classification of the miris human milk analyzer as a Class II breast milk macronutrients test system has created a defined pathway for clinically oriented analyzer adoption.

U.S. Human Milk Analyzers Market Trends

The U.S. market is supported by hospitals and milk banks investing in dedicated analytical capacity. In 2026, Miris reported orders from University Health Milk Bank in San Antonio and the University of Michigan Medical School, demonstrating demand from both milk-bank and academic settings. These installations strengthen the role of rapid macronutrient measurement in neonatal nutrition workflows. Accredited milk banks also operate with structured donor screening, processing, pasteurization, traceability, and inventory procedures, creating demand for reproducible analytical data.

Canada Human Milk Analyzers Market Trends

Canada benefits from established neonatal services and donor-milk infrastructure, although adoption is concentrated in specialized centers. Human milk banks and neonatal programs create opportunities for analyzers where milk composition must be assessed for individualized feeding or research. Procurement is therefore likely to favor validated systems that integrate with laboratory quality procedures and support repeatable measurements across hospital networks.

Europe Human Milk Analyzers Market Trends

Europe is a mature market supported by established neonatal care, public healthcare systems, research institutions, and milk-bank networks. Germany, the United Kingdom, France, and Spain are important markets, while declining birth volumes shift growth toward neonatal-care intensity, replacement demand, and milk-bank development. EU Regulation 2024/1938 broadened the substances-of-human-origin framework to include human breast milk and establishes requirements covering processing, quality control, storage, and distribution.

Germany Human Milk Analyzers Market Trends

Germany combines strong neonatal research capabilities with established healthcare infrastructure. Analyzer demand is supported by hospitals, research centers, and milk-bank activities requiring standardized nutritional assessment. The broader European regulatory shift toward documented quality and traceability should encourage demand for instruments that produce reproducible data within controlled workflows.

United Kingdom Human Milk Analyzers Market Trends

The United Kingdom has an extensive NHS neonatal network and established donor-milk services. For example, St Peter’s Hospital Milk Bank screens, pasteurizes, and microbiologically tests donor milk before use, with most donations supporting babies born before 32 weeks. Such structured handling illustrates how quality-controlled milk-bank workflows can create a role for analytical technologies alongside safety testing and clinical nutrition management.

Asia Pacific Human Milk Analyzers Market Trends

Asia Pacific is the fastest-growing regional market, supported by large newborn populations, expanding neonatal-care capacity, developing donor-milk networks, and improving hospital infrastructure. Southern Asia recorded a preterm birth rate of about 13.2% in 2020, while India was approximately 13.0%. China, Japan, India, and Southeast Asia present different adoption profiles, making localized regulatory, training, and service strategies important.

China Human Milk Analyzers Market Trends

China represents a major opportunity because of its large neonatal population and expanding milk-bank infrastructure. A 2025 expert consensus on donor human milk application and management in NICUs was developed by Chinese pediatric and neonatal organizations to address variation in clinical practice. This move toward standardized donor-milk management can support more structured quality assessment and increase the relevance of analytical tools in NICU workflows.

India Human Milk Analyzers Market Trends

India offers substantial long-term potential through government-supported lactation infrastructure. The National Health Mission describes Comprehensive Lactation Management Centers as facilities for collecting, screening, processing, storing, and distributing donor human milk, particularly for sick, preterm, and low-birth-weight infants. Expansion of these centers creates a foundation for analyzer adoption as milk banks seek better nutritional characterization and process control. Indonesia also reported exclusive breastfeeding rising to 66.4% in 2024, reinforcing broader regional investment in infant nutrition systems.

human-milk-analyzers-market-outlook-by-region-2026-2033

Competitive Landscape

The global human milk analyzers market is moderately concentrated among specialized suppliers but more fragmented when adjacent spectroscopy and laboratory-equipment providers are included. Miris has an established position in dedicated human milk analysis, with approximately 550 HMA instruments installed across 54 countries according to company reporting. Other participants compete through NIR, MIR, FT-IR, and broader milk-analysis technologies.

Leading companies are focusing on clinical validation, regulatory compliance, geographic expansion, workflow integration, service contracts, and software-enabled nutrition management. Differentiation increasingly depends on analytical reliability and clinical usability rather than hardware specifications alone. Emerging business models combine analyzers with software, calibration services, training, maintenance, and recurring support to increase utilization and strengthen customer relationships.

Key Industry Developments

  • In June 2026, Miris AB announced that the University of Michigan had invested in an additional Miris HMA® system, expanding the use of dedicated human milk analysis technology at a major U.S. academic medical center.
  • In February 2026, Prolacta Bioscience announced that Japan's Ministry of Health, Labour and Welfare had approved its PreemieFort® Enteral Solution as a prescription medicine for vulnerable infants, following clinical evidence from the JASMINE trial.

Companies Covered in Human Milk Analyzers Market

  • Miris AB
  • KPM Analytics
  • Scope Electric
  • EKF Diagnostics Holdings plc
  • FOSS Analytical A/S
  • MyMilk
  • BOE Technology Group Co., Ltd.
  • Medela AG
  • Medolac Laboratories
  • Prolacta Bioscience
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Bruker Corporation
  • Shimadzu Corporation
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
Frequently Asked Questions

The global human milk analyzers market is valued at US$342.7 million in 2026.

The human milk analyzers market is expected to reach US$522.1 million by 2033.

Key trends include the adoption of portable analyzers, individualized neonatal nutrition, expansion of human milk banks, NIR-based rapid analysis, and integration of milk-analysis data with digital clinical nutrition systems.

By analyzer type, portable human milk analyzers lead with approximately 63.5% share. By technology, NIR analyzers lead with approximately 57.6% share.

The human milk analyzers market is projected to grow at a 6.2% CAGR from 2026 to 2033.

Major players include Miris AB, FOSS Analytical A/S, KPM Analytics, Medela AG, and Prolacta Bioscience.

UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
USA

Regional Office

Persistence Market Research

108 W 39th Street, Ste 1006,PMB2219, New York, NY 10018

+1 646-878-6329
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

6th Floor, Teerth Technospace, Teerth Realties, Office No. B- 604, Baner, Pune, Maharashtra 411045

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -